The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients toward higher-priced insulin in order to reap ...
The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...
“Pharmacy benefit managers (were) to make sure there wasn’t misuse ... Because that’s not the direction we should be moving,” ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
OPINION - Patients rely on the quality care services provided by pharmacists and pharmacies. On behalf of pharmacies and the ...
PBMs have been under fire for years for alleged profiteering and anticompetitive conduct, but efforts to regulate the industry at the federal level have stalled in Congress.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback